Nachrichten zur Emergent Biosolutions Inc. Aktie

Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach

Emergent partners with the Armed Forces Research Institute of Medical Sciences for its capabilities in Chikungunya virus surveillance and field…

Emergent BioSolutions Shares Drop 32% After Wider-Than-Expected 3Q Loss

Emergent BioSolutions Shares Drop 32% After Wider-Than-Expected 3Q Loss...…

Emergent BioSolutions (EBS) Q3 2022 Earnings Call Transcript

EBS earnings call for the period ending September 30, 2022....…

Emergent Biosolutions (EBS) Reports Q3 Loss, Misses Revenue Estimates

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -2,016.67% and 10.51%, respectively, for the quarter ended September 2022. Do…

Form 8-K Emergent BioSolutions For: Nov 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines

GAITHERSBURG, Md., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced results from a Phase 2…

Emergent Biosolutions (EBS) Expected to Beat Earnings Estimates: Should You Buy?

Emergent Biosolutions (EBS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Emergent BioSolutions to Release Third Quarter 2022 Financial Results and Conduct Conference Call on November 8, 2022

GAITHERSBURG, Md., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call…

dpa-AFX ProFeed